Breathe: Slow Paced Breathing to Lower Blood Pressure
- Conditions
- High Blood Pressure
- Interventions
- Device: RESPeRATEBehavioral: Guided Breathing
- Registration Number
- NCT00328016
- Lead Sponsor
- National Institute on Aging (NIA)
- Brief Summary
The purpose of this study is to investigate the nature of the physiological reasons for the decreases in resting blood pressure that can result from systematic practice of computer-guided breathing exercises or meditative relaxation.
- Detailed Description
In this randomized clinical trial, persons with moderately elevated blood pressure were trained in either computer-guided breathing exercises or meditative relaxation to breathing. The computer-guided breathing exercise involves listening to tones of ascending and descending pitch to which breathing is entrained to low frequencies over a 15 minute interval. The meditative relaxation involves passive attention to natural breathing for the same duration. Participants will perform these breathing exercises daily at home for four weeks. Before and after the intervention, respiratory, cardiovascular, and urinary endogenous digitalis-like factors will be systematically recorded to determine the extent to which chronic neuroendocrine changes underlie the reductions in blood pressure.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 44
- Over 21 years
- Systolic blood pressure 130-160 or diastolic blood pressure 85-100
- More than one antihypertensive medication
- Beta blockers, angiotensin converting enzyme inhibitors or angiotensin receptor blockers
- History of coronary artery disease, heart failure, stroke, angina or coronary revascularization
- Kidney disease, defined as plasma creatinine > 1.5mg/dL
- Diabetes, defined by insulin or oral hypoglycemic medication or blood sugar > 126mg/dL
- Pulmonary disease, defined as chronic obstructive pulmonary disease, bronchitis, asthma, or use of inhaler
- Upper respiratory infection during past 30 days
- Medication that affects central nervous system function
- Steroid use
- Current pregnancy or lactation within past six months
- Current birth control medication or hormone replacement therapy
- Condition that in the judgment of the Principal Investigator is incompatible with the research study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Device Guided Breathing RESPeRATE Individual breathing rate was determined from an expandable band around the torso connected to a commercially available device (RESPeRATE, Lod, Israel) that presented distinctive tones via earphones. Control Group Guided Breathing Control group were instructed to sit in the same manner passively attend to their breathing, and silently repeat 'one' during each exhalation. If other thoughts came to mind, they were instructed to calmly attend to their breathing.
- Primary Outcome Measures
Name Time Method Breathing Rate After 15 minutes of guided breathing or control task Breathing rate was monitored continuously via inductive plethysmography.
- Secondary Outcome Measures
Name Time Method Minute Ventilation After 15 minutes of guided breathing or control task Minute Ventilation was continuously monitored via inductive plethysmography
End Tidal CO2 (PetCO2) After 15 minutes of guided breathing or control task End tidal CO2 was monitored continuously using a respiratory gas monitor
Trial Locations
- Locations (1)
NIA Clinical Research Unit
🇺🇸Baltimore, Maryland, United States